Diabetes Mellitus, Type 2: all 9,590 studies
Page 69 of 96. Open to participants first (1,331), then studies with results posted, then the rest; newest registration first within each.
- Effects of Sitaglpitin on Endothelial Function During the OGTT in T2DMStatus unknownNCT02301806Phase 4
- The Survey of Ipragliflozin Treatment in Elderly type2 Diabetes PatientsCompletedNCT02297620
- EMMA: Empowerment, Motivation and Medical AdherenceStatus unknownNCT02295696Not applicable
- A Sardine Diet Intervention Study to Assess Benefits to the Metabolic Profile in Type 2 Diabetes Mellitus PatientsCompletedNCT02294526Not applicable
- Variation of Glucose Values at Early Stages of Diabetes - Continuous Glucose MonitoringCompletedNCT02294370
- Continuous Glucose Monitoring in Youth With Type 2 DiabetesCompletedNCT02293577
- Evaluation of Stendo Pulsating Suit on Microcirculation and Endothelial Function in Diabetic PatientsStatus unknownNCT02293135Not applicable
- Acute Effects of Inspiratory Muscle Exercise on Glucose Level and Glucose Variability in Patients With Type 2 Diabetes.Status unknownNCT02292810Not applicable
- Mind-motor Exercise in Older Adults With Type 2 Diabetes and Self-reported Cognitive ComplaintsCompletedNCT02292511Not applicable
- Trial for People With Established Type 2 Diabetes During RamadanCompletedNCT02292290Phase 4
- Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)CompletedNCT02291874Phase 4
- Evaluation of CYP450 Activities in Diabetic Patients vs. Non-diabetic SubjectsCompletedNCT02291666Phase 4
- Screening Type 2 Diabetes Mellitus on the 2nd Day After Delivery in Women With Gestational Diabetes MellitusCompletedNCT02290860Not applicable
- Roux-en-Y Gastric Bypass (RYGB) Versus Omega-Loop Gastric Bypass (OLGB) Safety and Efficacy Short-term StudyStatus unknownNCT02290418Not applicable
- An Observational Study to Evaluate Cardiovascular Outcomes of T2DM PatientsTreated With GemigliptinCompletedNCT02290301
- Glycemic and Satiety Response Study of Fibre-Enriched Pudding ProductsCompletedNCT02289612Not applicable
- Effects of Ginger on Nonalcoholic Fatty Liver Disease in T2DMCompletedNCT02289235Early Phase 1
- The Effect of Plant Sterols on the Blood Lipid Profile of Subjects With and at High Risk of Type 2 Diabetes MellitusCompletedNCT02288585Not applicable
- Determinants of Diabetes Remission After Gastric Bypass SurgeryCompletedNCT02287285Early Phase 1
- Effect of NF-кB Dependent Proinflammation on Osteogenic Differentiation of the Mesenchymal Stem Cells in Type 2 DiabetesCompletedNCT02286128
- Effects of Saxagliptin on Adipose Tissue Inflammation in HumansCompletedNCT02285985Phase 4
- Shared Decision Making Between Patients and GPs in the Treatment of Type 2 Diabetes in Primary Care.CompletedNCT02285881Not applicable
- A 24 Week, Multicenter, Prospective, Open-labeled, Single-arm, Exploratory Phase 4 Clinical Trial to Evaluate the Safety and Efficacy of Lobeglitazone in Decreasing Intrahepatic Fat Contents in Type 2 Diabetes With NAFLDCompletedNCT02285205Phase 4
- Study of REGN1193 in Patients With Type 2 Diabetes MellitusTerminatedNCT02284425Phase 1
- Meta-analysis in Post-marketing Surveillances for SGLT2 Inhibitors in Patients With Type 2 Diabetes MellitusStatus unknownNCT02284269
- Diabetes Effects on Long-Term Implant Survival and SuccessCompletedNCT02282046
- Efficacy and Safety of Saxagliptin VS. Glimepiride in Chinese T2DM Patients Controlled Inadequately With MetforminCompletedNCT02280486Phase 4
- Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic PatientsTerminatedNCT02274740Phase 2
- Effects of Genmont Probiotic on Improve the Level of Blood Glucose and Other Diabetic Associate Parameter in Type 2 Diabetes PatientsCompletedNCT02274272Phase 2
- GOS and Insulin SensitivityCompletedNCT02271776Not applicable
- A German Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Type 2 Diabetes Patients.CompletedNCT02268929Not applicable
- Fat-induced Release of GLP-1 in HumansCompletedNCT02264951Not applicable
- A Clinical Trial to Study the Effect of Lycopene in Patients With Gum Disease and type2 Diabetes MellitusCompletedNCT02263352Phase 4
- Exercise as a Tool for Studying the Mechanisms and Applicability of Glycemic VariabilityStatus unknownNCT02262208Not applicable
- The Effect of n-3 Fatty Acid Supplementation on Serum Levels, and Gene Expression of type2 Diabetes PatientStatus unknownNCT02261545Phase 4
- Day-Night Rhythm in Human Skeletal MuscleCompletedNCT02261168Not applicable
- Insulin Sensitivity, Irisin and Adipokines as Outcome Parameters in Patients Undergoing Cardiac SurgeryCompletedNCT02258698
- The Features Behind the Beneficial Effects of Interval-walkingCompletedNCT02257190Not applicable
- Plant-based Ingredient on Post Prandial Glucose in Type II DiabetesCompletedNCT02256332Not applicable
- Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily PracticeCompletedNCT02255266
- Forxiga (Dapagliflozin) Regulatory Postmarketing SurveillanceCompletedNCT02252224
- Milk Plus Exercise: A Novel Strategy to Treat Diabetes.CompletedNCT02251301Not applicable
- Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical UnitWithdrawnNCT02250794Phase 4
- Safety and Tolerability Study of Oral LGD-6972 for Type 2 Diabetes MellitusCompletedNCT02250222Phase 1
- Prevention of Type 2 Diabetes Mellitus by Changes in DietCompletedNCT02250066Not applicable
- "Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic PopulationStatus unknownNCT02248311
- The Role and Effectiveness of Diabetes Coaches in British ColumbiaCompletedNCT02247271Not applicable
- Influence of Diabetes on Tramadol PharmacokineticsCompletedNCT02246712Phase 4
- Canola-Mediterranean Diet Study in T2DMCompletedNCT02245399Not applicable
- Effects of Resveratrol on Inflammation in Type 2 Diabetic PatientsCompletedNCT02244879Phase 3
- Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.TerminatedNCT02244164Not applicable
- Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes SubjectsCompletedNCT02242149Phase 3
- Diabetes Prevention Among Post-partum Women With History of Gestational DiabetesCompletedNCT02240420Not applicable
- Clinical Study to Evaluate the Efficacy of Anakinra in Patients With Rheumatoid Arthritis and DiabetesTerminatedNCT02236481Phase 4
- Pleiotropic Effects of Azilsartan Medoxomil Over Insulin Resistance in Obese, Diabetic and Hypertensive PatientsStatus unknownNCT02235519Phase 2/3
- Effects of an Amino Acid and Chromium-picolinate Containing Drink on Glucose MetabolismCompletedNCT02235194Not applicable
- Transformation of Indigenous Primary Healthcare DeliveryCompletedNCT02234973
- Chromosomal Damage in Type 2 Diabetes Patients (MIKRODIAB)Status unknownNCT02231736
- The Practical Evidence of Antidiabetic Combination Therapy in KoreaCompletedNCT02231021Phase 4
- A Survey on Hypoglycaemia Among Insulin-treated Patients With DiabetesCompletedNCT02230631
- Post Marketing Surveillance (PMS) Study of Ryzodeg™ (Insulin Degludec/Insulin Aspart) in Patients With Diabetes Mellitus in Routine Clinical Practice in IndiaCompletedNCT02230618
- Metabolic Activation With Protein-rich Formula DietCompletedNCT02230501Not applicable
- Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes MellitusWithdrawnNCT02229240Phase 3
- Effectiveness of a Computerised Prompt for Primary and Secondary Care Physicians to Refer or Refer Back Type 2 Diabetes PatientsCompletedNCT02229110Not applicable
- A Pilot Open Label Clinical Trial to Evaluate the Combined Impact of Two Mobile Health Products on Health Outcomes in Overweight Adults With Type 2 DiabetesCompletedNCT02227303Not applicable
- Ease of Use and Safety of the New U300 Pen Injector in Insulin-Naïve Patients With T2DMCompletedNCT02227212Phase 3
- DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Setting in JapanCompletedNCT02226822
- Effect of Paired Testing to Poorly Controlled Chinese Diabetes on Glycemic Control and Self CareStatus unknownNCT02225691Not applicable
- Trial to Incentivise Adherence for DiabetesCompletedNCT02224417Not applicable
- Safety, Pharmacokinetics, and Pharmacodynamics Study of Single Dose of CNTO 3649 in Healthy Adult Men and Multiple Doses of CNTO 3649 in Participants With Type 2 Diabetes MellitusCompletedNCT02224118Phase 1
- The Inova Type 2 Diabetes Mellitus StudyWithdrawnNCT02222623Not applicable
- Phase 2 Study of DS-8500a in Patients With Type 2 DiabetesCompletedNCT02222350Phase 2
- Diagnostic Biomarkers Related to Periodontal Disease Activity in DiabeticCompletedNCT02220751Phase 3
- Diabetes & VardenafilCompletedNCT02219646Phase 2
- A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney DiseaseCompletedNCT02218099Phase 1/2
- Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight AdolescentsCompletedNCT02216552Phase 2/3
- A Pilot Study To Examine The Effects Of Ticagrelor To Protect Against Type 2 Diabetes-Induced Vascular DamageStatus unknownNCT02214654
- Resilient, Empowered, Active Living: REAL Diabetes StudyCompletedNCT02214641Not applicable
- Mobile Unit Screening of Pathologies Associated With Chronic Diseases - FeasibilityCompletedNCT02214056
- Comparison of Postprandial Glucose Control Associated With BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500CompletedNCT02212951Phase 1/2
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 14332 CL as Tablet in Female and Male Patients With Type 2 DiabetesTerminatedNCT02212925Phase 1
- A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 DiabetesCompletedNCT02212067Phase 1
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 44847 in Female and Male Patients With Type 2 DiabetesCompletedNCT02211963Phase 1
- Maternal Adipose Tissue and Placental Dysfunction Programs the Fetus for Type 2 Diabetes (PlacentA-DM)CompletedNCT02211651
- Investigating the Pharmacokinetics, Safety and Tolerability After a Single Subcutaneous Injection of Semaglutide in Subjects With Mild, Moderate or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic FunctionCompletedNCT02210871Phase 1
- An Observational, Cross Sectional Study to Assess the Prevalence of Chronic Kidney Disease (CKD) in Type 2 Diabetes PatientsCompletedNCT02208921
- Weight Loss-Independent Metabolic Effects of Roux-En-Y Gastric Bypass in DiabetesCompletedNCT02207777Not applicable
- The Effect of Dietary Nitrate Supplementation on Ability of Individuals With Type 2 Diabetes to Perform ExerciseCompletedNCT02206074Not applicable
- The Effects of Hypoglycaemia in People With Type 2 DiabetesCompletedNCT02205996Not applicable
- A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With MetforminCompletedNCT02205528Phase 2
- EXIT: Prospective Study of the Response to ExerciseCompletedNCT02204670
- Glycemic and Insulinemic Response With Different Sources of Soluble Fiber in Patients Type 2 Diabetes MellitusCompletedNCT02204384Not applicable
- Redox Imbalance and the Development of Cystic Fibrosis DiabetesCompletedNCT02202876Not applicable
- Study of Immune Cells in Obese Patients With Type 2 Diabetes Mellitus Treated With LiraglutideCompletedNCT02201550
- TOFO Insulin Combination TrialCompletedNCT02201004Phase 4
- Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin GlargineCompletedNCT02200991Phase 4
- Forxiga Tablets Specific Clinical Experience Investigation for Long-term UseCompletedNCT02200666
- Forxiga Tablets Specific Clinical Experience Investigation for ElderlyCompletedNCT02200627
- A Study to Compare Insulin Pump With Conventional Treatment in Type 2 DiabetesStatus unknownNCT02198846Not applicable
- Improving Glycaemic Control With L-carnitineStatus unknownNCT02197299Phase 2